APA (7th ed.) Citation

RC, T., NE, K., SA, P., KG, R., P, S., A, P., . . . DF, J. (2026). Proteomic and phosphoproteomic signatures of disease progression in unmutated IGHV chronic lymphocytic leukemia. Clinical proteomics, 23(1), . https://doi.org/10.1186/s12014-026-09607-2

Chicago Style (17th ed.) Citation

RC, Tschumper, Kay NE, Parikh SA, Rabe KG, Sen P, Pandey A, Kandasamy RK, and Jelinek DF. "Proteomic and Phosphoproteomic Signatures of Disease Progression in Unmutated IGHV Chronic Lymphocytic Leukemia." Clinical Proteomics 23, no. 1 (2026). https://doi.org/10.1186/s12014-026-09607-2.

MLA (9th ed.) Citation

RC, Tschumper, et al. "Proteomic and Phosphoproteomic Signatures of Disease Progression in Unmutated IGHV Chronic Lymphocytic Leukemia." Clinical Proteomics, vol. 23, no. 1, 2026, https://doi.org/10.1186/s12014-026-09607-2.